Yayın:
Is it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al.

Sadeleştirilmiş öğe sayfası
dc.contributor.authorŞimşek, Eda Tanrıkulu
dc.contributor.authorBatuhan Bayram
dc.contributor.authorAlev Yıldırım
dc.contributor.authorAhmet Emre Eşkazan
dc.contributor.orcid0000-0001-9568-0894
dc.date.accessioned2025-11-13T19:39:14Z
dc.date.issued2022-03-23
dc.identifier.doihttps://doi.org/10.1016/j.tranon.2022.101403
dc.identifier.endpage101403
dc.identifier.issn1936-5233
dc.identifier.openalexW4220868830
dc.identifier.startpage101403
dc.identifier.urihttps://hdl.handle.net/11421/11463
dc.identifier.urihttps://doi.org/10.1016/j.tranon.2022.101403
dc.identifier.volume20
dc.language.isoen
dc.relation.ispartofTranslational Oncology
dc.rightsopenAccess
dc.subjectMedicine
dc.subjectPathological
dc.subjectChemotherapy
dc.subjectMonocyte
dc.subjectOncology
dc.subjectLymphocyte
dc.subjectCorrelation
dc.subjectNeoadjuvant therapy
dc.subjectBreast cancer
dc.subjectComplete response
dc.subjectInternal medicine
dc.subjectImmunology
dc.subjectPathology
dc.subjectCancer
dc.subject.sdg3
dc.titleIs it possible to predict the pCR with CBC? A commentary on “correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer” by Meng et al.
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5019055570

Dosyalar

Koleksiyonlar

Publications